Prevalence and risk of oral adverse outcomes in patients with COVID-19: a retrospective real-world cohort study.

Publication date: Jul 01, 2026

Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, affects multiple systems, including the oral cavity, with ulcers, taste changes, and mucosal lesions. Existing studies are limited in scope, highlighting the need for large-scale studies to clarify the prevalence and clinical relevance of these oral outcomes. We conducted a retrospective cohort study using the TriNetX Research Network to analyze COVID-19 patients from 2020 to 2025. Queried oral conditions, including ulcers, taste alterations, salivary disturbances, and mucosal lesions. Propensity score matching was used to balance age, sex, and comorbidities. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated, with significance set at P

Concepts Keywords
Coronavirus Adult
Taste Aged
Ulcers COVID-19
Female
Humans
Male
Middle Aged
Mouth Diseases
Prevalence
Retrospective Studies
Risk Factors
Taste Disorders

Semantics

Type Source Name
disease MESH COVID-19
disease MESH ulcers
drug DRUGBANK Isoxaflutole
disease MESH aphthous ulcers
disease MESH stomatitis
disease MESH Long Covid
disease MESH Mouth Diseases
disease MESH Taste Disorders

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *